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Historical vignette
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v" Irving S. Cooper (1922-1985), the son of a salesman, worked his way through high school, college, and medical 
school to become one of the pioneers in functional neurosurgery. He developed several novel techniques for the sur­
gical management of Parkinson’s disease and other crippling movement disorders. A keen interest in the physiology 
of movement disorders was kindled by his doctoral research and continued during his neurosurgical training. He began 
to apply this knowledge to surgical practice in 1952 when he began his faculty career as Assistant Professor of Surgery 
at New York University. At the time, surgical treatment of parkinsonian tremor focused on various techniques used to 
interrupt the pyramidal tract. During a subtemporal approach for a cerebral pedunculotomy, he inadvertently injured 
and, subsequently, was forced to occlude the anterior choroidal artery. Much to Cooper’s surprise, following emer­
gence from anesthesia the patient’s tremor and rigidity were abolished without any residual hemiparesis. This serendip­
itous observation, together with Meyer’s earlier work on the role of the basal ganglia in motor control, helped focus 
surgical efforts on targets within the basal ganglia and, subsequently, within the thalamus to alleviate the movement 
disorders associated with Parkinson’s disease. While at New York University, Cooper developed chemopallidectomy 
and, later at St. Barnabas Hospital in the Bronx (1954-1977), he used cryothalamectomy as a surgical technique for 
primary control of tremor in patients with Parkinson’s disease. Cooper authored many original papers on surgical tech­
niques and several textbooks on the lives of patients afflicted with Parkinson’s disease and other crippling movement 
disorders. Although considered controversial, this fascinating and complex neurosurgeon made significant contribu­
tions to this field.
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I r v i n g  S. Cooper was born in Atlantic City, New Jersey on July 15, 1922 to Lewis and Lillian Cooper. His father, who was one of 11 brothers, worked as a busi­
nessman supplying kitchen equipment to hotels in At­
lantic City. Irving had one brother, David, who also be­
came a physician. During the Great Depression the family 
business experienced difficult times and at one point they 
were forced to leave their home and live with other fami­
lies. As a result, young Irving worked during high school 
and college to help finance his education. He attended 
public schools as a child and enrolled in undergraduate 
studies at George Washington University in Washington, 
D.C. Cooper worked during college delivering meat to 
help pay his tuition. Interestingly, his initial intent to pur­
sue a career in law was changed after a customer com­
mented that his appearance was more suited to someone in 
the medical profession.
Cooper completed a Bachelor of Arts degree at George 
Washington University in 1942. He continued his stud­
ies at George Washington University for his doctorate in 
medicine, which he completed in 1945 (Fig. 1). An intern­
ship at the United States Naval Hospital in 1946 was fol­
lowed by neurosurgical training at the Mayo Clinic in 
Rochester, Minnesota. During this time, Cooper also 
earned a Masters degree followed by a doctorate in neu­
rophysiology from the University of Minnesota. It was 
during this period that he developed an interest in physi­
ology, which specifically fueled his interest in studying 
the neurophysiological mechanisms underlying move­
ment disorders. Following his neurosurgical training at the 
Mayo Clinic, which lasted from 1948 to 1951, he accept­
ed a faculty appointment at New York University (NYU). 
Early in his career he performed most of his clinical work 
at Bellevue Hospital in New York City. In 1954 he orga­
nized the Department of Neurosurgery at St. Barnabas 
Hospital in New York City, where he subsequently per­
formed thousands of operations for the treatment of move­
ment disorders. In 1977 Dr. Cooper left NYU and was 
appointed Director of the Center for Physiologic Neu­
rosurgery at Westchester County Medical Center and Re­
search Professor of Neuroanatomy at New York Medical 
College in valhalla, New York, positions he held until his 
death in 1985.
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Fig. 1. Photograph of Irving S. Cooper, circa 1947. Courtesy of 
John Hogle, photographer.
Foundations of Functional Neurosurgery
At the time Cooper completed his neurosurgical train­
ing, surgical management of movement disorders focused 
on the treatment of Parkinson’s disease. In the 1930s and 
1940s there were a large number of patients with posten­
cephalitic Parkinson’s disease.84 Medical therapy was lim­
ited, leaving surgery as the sole method available to alle­
viate the patients’ distressing tremor. During this period, 
operations had been devised to attack all levels of the ner­
vous system, including the cerebral cortex,10-12 cerebral 
peduncle,8,95 and spinal cord84 to the radicular level. Neu­
rosurgical procedures for Parkinson’s disease were initial­
ly aimed at the pyramidal tract and operations were de­
vised to resect either the premotor or motor area itself for 
tremor ablation. In 1940 Klemme74 described 100 re­
sections of the premotor cortex; in 39 patients relief of 
tremor was achieved with no significant neurological 
deficit. In the series by Bucy10 reported in 1942, both the 
premotor and motor cortex were resected; this initially 
produced plegia, but ultimately left the patient hemiparet- 
ic although without tremor. Subsequent to this, Putnam85 
devised the operation of pyramidotomy, which consisted 
of incising the pyramidal tract at the second cervical level 
of the spinal cord. Walker95 introduced the pedunculoto­
my, which involved interrupting the pyramidal tract at the 
level of the midbrain; this was considered superior to cor­
tical resection in that it avoided the convulsions associat­
ed with cortical resection. All of these procedures relieved 
tremor at the expense of motor function and did nothing to 
address the other cardinal manifestations of Parkinson’s 
disease (rigidity and akinesia).
Major advances in the surgical therapy of Parkinson’s 
disease occurred when the focus shifted to targets within 
the basal ganglia and thalamus. Meyers issued his pio­
neering reports78,79 on a series of operations that revealed 
that sectioning of the pallidofugal fibers emerging from 
the medial globus pallidus resulted in improvement in 
both tremor and rigidity. Following these reports, other 
surgeons, including Spiegel and Wycis,9091 produced sim­
ilar lesions in the pallidofugal fibers by using stereotactic 
localization. They reported reduction in tremor and rigid­
ity without paralysis in four of six patients.91 Fenelon and
Thiebaut69 devised a direct method for ansa lenticularis 
coagulation in which a transfrontal approach was used to 
pass an electrode transcortically to make a lesion. Using a 
subfrontal approach, Guiot and Brion directly coagulated 
the mesial globus pallidus; in this series71 42.5% of pa­
tients had an excellent outcome.
Cooper’s Pioneering Work
Surgical Occlusion o f the Anterior Choroidal Artery
During his career, Cooper developed several novel 
techniques for the surgical management of Parkinson’s 
disease and other movement disorders. Perhaps none was 
more notable than the one inadvertently selected in Octo­
ber 1952, when Cooper was performing the approach to a 
pedunculotomy (as described by Walker) in a 39-year-old 
man who was incapacitated by postencephalitic tremor, 
right hemirigidity, and severe retrocollis. Using a subtem­
poral approach, the arachnoid just above the tentorium 
was opened with a sharp hook; an artery coursing in the 
region was torn, bled profusely, and was subsequently oc­
cluded with silver clips. The pedunculotomy was abort­
ed. When the man emerged from anesthesia, much to 
Cooper’s surprise the patient’s tremor and rigidity were 
abolished although his motor and sensory function re­
mained intact. The postoperative angiogram showed that 
the anterior choroidal artery had been occluded. Cooper 
concluded that the unintentional occlusion of the anterior 
choroidal artery resulted in a medial globus pallidal in­
farction that alleviated the patient’s tremor and rigidity.14 
This hypothesis was consistent with anatomical work per­
formed in animals by Alexander.1 The next logical step 
Cooper pursued was to occlude the anterior choroidal 
artery purposefully in patients with advanced Parkinson’s 
disease. Over the next 3 years, Cooper occluded the ante­
rior choroidal artery in 50 patients (Fig. 2). He reported 
excellent results in 65% of cases, noting improvements in 
tremor, rigidity, bradykinesia, and gait disturbances.14,43 A 
battery of tests performed by a team of independent 
observers including neurologists, physiatrists, and psy- 
cholgists was used to evaluate outcome in this series.3341 
Patients underwent a thorough physical examination, neu­
rological examination, psychological studies, speech eval­
uation, and electromyographic and cinematographic re­
cordings. In addition, patients’ subjective impressions and 
observations made by relatives, nurses, and referring med­
ical doctors were made part of the permanent medical rec­
ords. Complications included an operative mortality rate 
of 10%, three cases of hemiplegia, one case of moderate 
aphasia, and one case of quadrantic hemianopsia.9,73,81
The main difficulties encountered with anterior choroi­
dal artery occlusion were the inconsistent results that were 
obtained and the complications related to the variable ter­
ritory of the basal ganglia that the artery irrigated.44 In 
autopsy series and primate models, it was found that the 
anterior choroidal artery supplies medial and intermediate 
portions of the globus pallidus.57 However, particularly in 
elderly patients with occlusive vascular disease, it can also 
supply the posterior portion of the internal capsule.80 
Cooper believed this was the reason why hemiparesis was 
more common in this latter group of patients. Given the 
results of his surgical experience,515266 he recommended
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Fig. 2. Left: Diagram illustrating the surgical technique of occlusion of the anterior choroidal artery by vascular clips. 
The temporal craniectomy and subtemporal approach are shown. Right: Diagram showing the territory of irrigation of 
the anterior choroidal artery demonstrating the supply to the medial basal ganglia. Reproduced with permission from 
Cooper IS: Parkinsonism: Its Medical and Surgical Therapy. Springfield, Ill: Charles C Thomas, 1961.
that the procedure only be performed in patients younger 
than 55 years of age.
Chemopallidectomy and Chemothalamectomy
The experience with anterior artery occlusion had 
suggested that the motor symptoms of tremor, rigidity, 
and bradykinesia from Parkinson’s disease could be im­
proved by lesioning the basal ganglia. Through retrospec­
tive analysis, it was determined that patients with uni­
lateral tremor, rigidity, and motor difficulties were ideal 
candidates for surgery. However, there was a need for a 
procedure that was safer and would provide more consis­
tent results.
In September 1953 Cooper conceived the idea of che- 
mopallidectomy as an alternative means of creating a le­
sion within the globus pallidus. For this surgery, patients 
first underwent preoperative pneumoencephalography for 
radiographic localization. Using the pallidectomy guide,83 
a cannula was then inserted through a small trephine so 
that the tip of the cannula could be placed in the medial 
globus pallidus (Fig. 3). After local anesthesia had been 
induced in the patient, a test lesion was created by pro­
caine injection; if this resulted in alleviation of contralat­
eral tremor and rigidity, a destructive lesion was created 
by an injection of absolute alcohol.1627
As his experience using this technique increased, 
Cooper found that occasionally the procaine would reflux 
along the path of the cannula or would be diluted by ex­
tracellular fluid, making results unreliable. He therefore 
sought a more reliable method for producing a test lesion. 
By injecting air or liquid into the lumen of a small inflat­
able balloon, a test compressive lesion was produced. If 
successful, this would be followed by creation of the per­
manent destructive lesion (Fig. 4).29 Cooper reported a 
mortality rate of less than 3% in his series of 70 patients 
who underwent chemopallidectomy that was performed 
using this technique.14-20-35-36-59 Instances of morbidity 
consisted of only one case of hemiplegia and six cases of 
transient hemiparesis. This early experience, in which the 
coordinates developed at the time were used, also sug­
gested that pallidotomy was best for treating rigidity but 
somewhat inconsistent for treating tremor.5-6 16 17-21-37-49-56-57
Hassler’s seminal work in the early 1950s72-73 helped 
determine that the main outflow of the medial globus pal­
lidus was to the ventrolateral thalamus. Almost at once 
Cooper and Bravo and their colleagues5-17-19-20-40-53-76-77 and 
Hassler and Reichert72,73 started producing lesions by us­
ing stereotactic techniques in the ventrolateral thalamus. 
Thalamotomy proved to be more effective in alleviating 
tremor.34-48-67-68-76-77 Along with interruption of the pallidal 
thalamic fibers in the subthalamus, thalamotomy rapidly 
became the operation of choice for the treatment of tremor 
caused by Parkinson’s disease.86-88 In 1960, Cooper42 pub­
lished the results of a series of 1000 consecutive opera­
tions on the basal ganglia and thalamus for Parkinson’s 
disease with an impressive rate of success and a low rate 
of complications.
Cryothalamectomy
While at St. Barnabas Hospital, Cooper developed an 
alternative technique for creating lesions in the basal gan­
glia and thalamus. He conceived the idea after receiving a 
carbon dioxide wine bottle opener as a gift. While using 
the bottle opener, he noticed the carbon dioxide cooling 
his hand and how much the device looked like a brain can­
nula. In 1960, with the help of Robert Johnson, an engi­
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Fig. 3. Left: Diagram illustrating the subtemporal trajectory initially used for passing the cannula into the globus pal­
lidus to perform chemopallidectomy in 1953. Right: Later, a frontal convexity approach was adopted to pass the can­
nula into the globus pallidus, similar to the approach utilized for performing contemporary pallidotomy. Reproduced with 
permission from Cooper IS: Parkinsonism: Its Medical and Surgical Therapy. Springfield, Ill: Charles C Thomas, 
1961.
neer, and Arthur Rinfret, a cryobiologist, Cooper designed 
the first cryosurgical probe for use in the brain.23-54-55 The 
instrument consisted of a cannula that was insulated on the 
sides but had an uninsulated tip so it could be cooled to 
produce a lesion. The first cryothalamectomy was per­
formed in October 1962.13-22 Using the same localizing 
techniques as those in his earlier operations, Cooper made 
a test lesion by cooling the area after the cannula was 
placed in the ventrolateral thalamus. If the patient’s tremor 
and rigidity were successfully abolished, liquid nitrogen 
(— 196°C) would be introduced into the cannula, freezing 
the tip of the cryoprobe and creating the ablative lesion 
(Fig. 5). Cryosurgery was also used to treat other move­
ment disorders,65 most notably lesioning of the pos- 
teroventrolateral area of the thalamus for the treatment of 
dystonia musculorum deformans.26-30-50 Cooper treated nu­
merous patients with Parkinson’s disease by using this 
technique; he reported a mortality rate of less than 1.5%- 
a success rate of 90% in good-risk patients, and a success 
rate of 60% in poor-risk patients.24-39-60-92-93 
Cooper has often been called the father of cryosurgery 
because of his development of cryosurgical equipment. 
Although others had preceded him in the use of freezing 
techniques to produce lesions in other organs, it is clear 
that Cooper’s leadership in the development of cryosurgi­
cal instrumentation in neurosurgery was a major stimulus 
toward the development of cryosurgical apparatuses and 
techniques in many other areas of medicine.64
Cerebellar and Deep Brain Stimulation
In the early 1970s Cooper began work on cerebellar and 
deep brain stimulation for the treatment of intractable 
epilepsy and spasticity.15-58 The foundation for this concept 
had been established in animal studies on cats that had 
demonstrated that stimulation of the anterior lobe of the 
cerebellum could ease decerebrate rigidity. While Cooper 
was a fellow at the Mayo Foundation, he discovered a 
report on the work of the Italian physiologist Giuseppe 
Moruzzi,82 who had noted that electrical stimulation of the 
cerebellum could inhibit or facilitate motion depending on 
the frequency applied. With the help of engineers, Cooper 
designed a stimulator that consisted of electrodes that 
would be placed on the cerebellum or in the posterior por­
tion of the ventrolateral nucleus of the thalamus adjacent 
to the internal capsule. The electrodes were then connect­
ed to wires that were tunneled under the skin to a genera­
tor embedded in the subcutaneous region of the chest. 
The work, which began in 1972, continued until Cooper’s 
death in 1985. Cooper published results of series of pa­
tients treated with chronic cerebellar stimulation and deep 
brain stimulation for the treatment of spasticity and in­
tractable seizures.52-61 He reported that 55% of patients 
experienced useful improvements.62 However, others who 
attempted controlled studies usually found negative or 
equivocal results when using these techniques.47 It is inter­
esting to note that recent work by Benabid and colleagues2 
and by others3,75 has renewed interest in the use of stimu­
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Fig. 4. Left: Diagram of the cannula with inflatable balloon used for chemopallidectomy. Reproduced with permis­
sion from Cooper IS: Parkinsonism: Its Medical and Surgical Therapy. Springfield, Ill: Charles C Thomas, 1961. 
Right: Photograph of the actual instrument. Once in place the balloon was inflated to make a test lesion before creating 
the permanent lesion by instilling absolute alcohol. Reproduced with permission from Bravo G, Cooper IS: Che- 
mopallidectomy-two recent technical additions. J Am Geriatr Soc 5:653, 1957.
lators for the treatment of Parkinson’s disease and other 
movement disorders.
A Controversial Academician
Cooper was a complex and charismatic man whose cre­
ativity, dedication to human welfare, and energy con­
tributed to his many achievements. However, during the 
most productive portion of his career, many colleagues 
found his work controversial. One may wonder why he 
provoked such strong emotional, frequently irrational, and 
destructive responses from his peers. There are a number 
of possible explanations for the behavior of the prominent 
and influential doctors at that time; however, probably 
none are completely satisfactory. It should be recognized 
that 40 years ago medical discussions were confined to 
peer-reviewed journals and the appearance of a young, 
attractive surgeon in the lay press or, worse yet, on televi­
sion was anathema to a large portion of the academic com­
munity. Also, Cooper’s somewhat brash, nondeterred ap­
proach did not sit well with some of his colleagues. Much 
of this was a matter of style, but acrimony regarding the 
man and his methods occasionally reflected on his work. 
In the introduction to Cooper’s autobiography The Vital 
Probe: My Life as a Brain Surgeon, Dr. Adrian Upton 
states “It is my view that a young physician could achieve 
a lifetime of negative results; such an individual would 
gain a reputation for honesty and integrity without the risk 
of jealousy or suspicion in his colleagues. However, a
young physician can expect nothing but trouble from an 
important and original discovery made early in his career. 
Such an individual would be wise to attribute his discov­
ery to luck rather than ability. An even more cynical 
thought is that a pioneer should develop some physical 
handicap (a limp, a stutter, or an eye patch) in order to off­
set jealousy with sympathy.”47 
To be sure, Dr. Cooper was in his early 30s when he 
reported his original observations about the basal ganglia 
and movement disorders. He believed that surgical treat­
ment would benefit patients afflicted with these crippling 
disorders. His attempts to widen the use of these proce­
dures were seen by many as self-promotion. Many per­
sons in the medical community criticized Cooper because 
he subjected patients to procedures that had not been con­
firmed in animal models or in controlled studies. In addi­
tion to this, his results often could not be reproduced by 
other surgeons. Cooper responded by saying that there 
were no suitable models for this disease: “I had the ulti­
mate responsibility to be right. I ’m treating desperate 
patients who come to me for help, not an experiment.”22 
The slightest rumor about exaggeration, hiding of ad­
verse results, personality problems, financial advantage, 
or harm to patients caused widespread criticism of Coop­
er’s entire body of work. Much smaller series of results 
were accepted without question, particularly if the conclu­
sions disagreed with the work of Cooper and his associ- 
ates.47 He was occasionally subject to illogical, unscientif­
ic, and emotional attacks, and even the results obtained
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Fig. 5. Upper: Photograph showing a cryosurgical probe being 
inserted while the patient is receiving localized anesthesia. After 
the probe is placed in position, a test lesion is made by cooling the 
probe to 0°C, followed by creation of a permanent lesion as the 
probe is cooled to — 196°C using liquid nitrogen. Center: As the 
test lesion is made, the patient is asked to open and close his hand 
to confirm accurate placement of the cryosurgical probe by assess­
ing rigidity, bradykinesia, and strength before creating the perma­
nent lesion. Lower: Photograph of the stereotactic apparatus used 
to perform cryothalamectomy, displaying the mechanical micro­
drive that is used to make fine adjustments to the probe position. 
Photographs courtesy of John Hogle, photographer.
from a single monkey experiment were used to negate 
results he reported from the surgical treatment of hundreds 
of patients.47
Once, during a meeting, after presenting results of his 
surgery, Cooper was criticized by persons in the audience 
who said his work was not performed scientifically and
Fig. 6. Photograph of Cooper speaking with the family of a girl 
with dystonia musculorum deformans prior to her surgery. Photo­
graph courtesy of John Hogle, photographer.
questioned its validity. Cooper responded by bringing pa­
tients out on the stage, one by one, after having shown 
films of their preoperative disabilities. Displays such as 
this were not looked on favorably by the medical commu­
nity at the time, and Cooper was viewed as a showman 
rather than a scientist. Dr. Cooper’s youth and enthusiasm 
continued to jar the academic community. He traveled the 
world speaking about his results, frequently to lay audi­
ences. His work was received more favorably outside the 
United States,18 especially in Europe where he was made 
a member of many prestigious neurosurgical societies. 
During his illustrious career he authored nearly 300 jour­
nal articles and several books about parkinsonism, other 
involuntary movement disorders, and surgical techniques.
To his credit, after learning about levodopa from the 
work of Dr. George Cotzias (Brookhaven National Lab­
oratory, Upton, New York), Cooper immediately deferred 
700 patients who were scheduled for surgery and enrolled 
them in one of the first clinical trials for the use of lev­
odopa for Parkinson’s disease at St. Barnabas Hospital.
Dr. Cooper was praised by many, such as British scien­
tist and author C.P. Snow89 who described Cooper as “pro­
fessionally one of the great brain surgeons of the world” 
and regarded him as a true innovator. Others saw Cooper 
as someone who publicized his results through his novels 
and by other means before going through the usual forum 
of peer review.
Irving S. Cooper, Author and Humanist
Cooper will always be remembered for his humanistic 
attitude in caring for patients (Fig. 6). He was the author 
of novels about the lives of patients afflicted with crip­
pling neurological diseases. He once stated “the patient is 
never free, because he is imprisoned by his disease.”46 In 
one of his novels, The Victim is Always the Same,46 Cooper 
describes the moral and ethical dilemma he encountered 
before surgically treating a young girl with dystonia mus­
culorum deformans25 whose case was deemed hopeless by 
other doctors:
How does one decide to place for the first time an instru­
ment deep in a child’s brain and destroy part of it? It’s not just
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a question of overcoming the technical difficulties, which can 
always be worked out in the laboratory. It’s a more profound 
moral question than that, because only human beings have this 
disease.32
Cooper stated that modern medicine has forced us to 
witness human suffering analytically and become de­
tached.
In my view when this occurs, the goal of medicine— to 
make sick people well, or failing that to relieve pain and suffer- 
ing— becomes obscured.45
He believed that understanding how illness affects pa­
tients and their entire families is something that is often 
overlooked and deemphasized in physician training. In his 
autobiographical novel The Vital Probe: My Life as a 
Brain Surgeon,47 Cooper highlighted some of the achieve­
ments of his remarkable career through vivid descriptions 
of surgery and the lives of the people he affected. He also 
expressed his rage at the blindness, arrogance, and petti­
ness of some established doctors of the time, who Cooper 
believed saw new discoveries as threats to their careers 
rather than hope for their patients. Cooper died of cancer 
in 1985. He is survived by his wife, five sons, and one 
daughter. Toward the end of his career, he founded the 
Cooper Institute for Advanced Studies in Medicine and 
the Humanities in Naples, Florida, which is now managed 
by his wife, Sissel Cooper.
Conclusions
Irving S. Cooper was a fascinating, complex, and con­
troversial man whose work constitutes an invaluable con­
tribution to the field of functional neurosurgery. Although 
he was criticized for the forum he used to convey his sur­
gical results, the significance of his contributions should 
not be overlooked. Those who knew him personally re­
member him as a charismatic, energetic, and innovative 
neurosurgeon who fostered a humanistic approach to 
treating patients afflicted with crippling neurological dis­
eases.
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